Create an account or log in to participate in this activity
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and New York Chapter, American College of Physicians. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Contact Hours: 1, of which 1 is eligible for pharmacology credit
In order to receive credit, participants must view the content, and complete the post-test and evaluation. Participants who receive a grade of 70% or greater on the post-test will receive credit.
In order to receive credit, participants must view the content complete the post-test and evaluation. Participants who receive a grade of 70% or greater on the post-test will receive credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This course will fulfill New York State's 3-hour CME educational course mandate on pain management, palliative care and addiction (Chapter 71 of the Laws of 2016). Participants will receive CME credit and MOC points for completing both this module AND the two SCOPE of Pain modules.
Every person licensed under Title 8 of the NYS Education Law with a DEA registration and every medical resident who is prescribing under a facility DEA registration number, including physicians, nurse practitioners, residents, registered nurses, nurses, physician assistants, dentists, and pharmacists.
At the conclusion of this activity, participants will be better able to:
Date of Original Release: February 26, 2023
Date of Most Recent Review: February 16, 2024
Date of Expiration: February 15, 2026
Estimated time to complete: 1 hour
For questions about CME, please contact cme@bu.edu.
The opioid epidemic has become a national public and safety problem affecting both adults and adolescents, and illicit opioids are contributing to the increase in opioid overdose deaths. The CDC has stated that "an estimated 1 out of 5 patients with non-cancer pain or pain-related diagnoses are prescribed opioids", that "nearly 2 million Americans abused or were dependent on prescription opioids in 2014", that "from 1999 to 2015, more than 180,000 people died from overdoses related to prescription opioids" and that "since 1999, sales of prescription opioids in the U.S. have quadrupled".
In New York State, there are various initiatives underway to address the state's current heroin and opioid crisis. While legally prescribed medications play an important role for the treatment and management of pain, there is also a 2016 mandate that requires prescribers to receive updated education on these medications, and the potential associated risks for patients.
Participants will satisfy requirements of New York State Law by completing three hours of Continuing Medical Education (CME) every three years. Specific elements contained within the NYS Department of Health mandated educational course content include:
In addition to satisfying the State's educational objectives, this activity offers pain reducing alternatives for managing pain in a continued effort to reduce the risk of opioid use and misuse.
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Daniel P. Alford, MD, MPH (CME Course Director)
Professor of Medicine
Boston University Chobanian & Avedisian School of Medicine
Boston Medical Center
Kristin Wason, MSN, NP-C, CARN (CNE Course Advisor)
Clinical Educator, Massachusetts OBAT TTA
Boston University Chobanian & Avedisian School of Medicine
Boston Medical Center
Paula Lester, MD, FACP, CMD
Member, Pain Course Task Force
New York Chapter American College of Physicians
Daniel Pomerantz, MD, MPH, FACP
Member, Pain Course Task Force
New York Chapter American College of Physicians
Kelly Ramsey, MD, MPH, MA, FACP
Member, Pain Course Task Force
New York Chapter American College of Physicians
Faculty members listed above have no relevant financial relationships to disclose. Faculty members listed above do not plan on discussing off-label/investigational uses of commercial products.
Ilana Hardesty, Program Operations Manager, BUSM; Paula E. Lester, MD, FACP, CMD; Daniel Pomerantz, MD, MPH, FACP; Kelly S. Ramsey, MD, MPH, MA, FACP; Linda S. Efferen, MD, MBA, MACP; Heather G. Bennett, JD, PhD, NYACP Executive Director; and Loretta A. Ponesse, CAE, NYACP Assistant Executive Director
Planning committee members have no relevant financial relationships to disclose.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
SCOPE of Pain
© 2025 Trustees of Boston University. Site by Root802.